Prostate Cancer, Bone Metastases, and a Difficult Question: Is More Treatment Always Better?
When men hear the words prostate cancer, especially when it has spread to the bone, the instinct is often immediate and powerful. Do everything possible. Fight hard. Act fast.
But not every physician frames the decision this way.
In a widely discussed talk on prostate cancer and bone metastases, Dr. Stephen Petteruti presents a very different perspective, one that places quality of life, patient autonomy, and skepticism of aggressive treatment at the center of the conversation.
His core message is simple, but provocative: “The message is: live life. Do not anticipate death. Maintain vitality. Nobody can guarantee us tomorrow.”
A Different Starting Point: Quality of Life First
Dr. Petteruti challenges a deeply ingrained assumption, that extending life at any cost is always the right goal.
He says, “I do not want to pay the price of today's misery for some false hope that it will make me live longer.”
That idea will resonate with many men facing difficult trade-offs. Some treatments may slow disease progression, but they can also carry serious physical and emotional costs.
It is important, however, to add balance here. Mainstream oncology does not usually present treatment as a simple choice between more life and more suffering.
In most cases, the goal is to balance survival, symptom control, and quality of life based on the stage of disease, the burden of symptoms, and the patient's own priorities.
His Criticism of Conventional Treatment
Standard treatment for metastatic prostate cancer often includes androgen deprivation therapy, often called ADT. This is an established medical approach designed to reduce testosterone levels and slow the growth of cancer.
Dr. Petteruti describes that approach in blunt language. He calls it “testosterone annihilation.”
He also describes what he sees as the human cost of that treatment: “You take testosterone out of your body, you're going to get tired, weak, develop breasts in all likelihood, your sex drive goes away, you get depressed. It is a horrible way to live.”
Those side effects are not imaginary. Fatigue, sexual dysfunction, loss of muscle mass, mood changes, and bone thinning are all recognized risks of ADT. But the severity varies. Some men tolerate treatment far better than others, and in many cases ADT can reduce symptoms, relieve pain, and prolong life.
Still, Dr. Petteruti believes the trade-off is too often underplayed. As he puts it, “And all that misery, and the cancer will eventually progress.”
That point needs context. In advanced metastatic prostate cancer, progression is common over time, but that does not mean treatment has no value. In many cases, treatment can extend meaningful survival and improve symptom control, even if it does not cure the disease.
Treating a Number vs Treating a Man
One of Dr. Petteruti's most important arguments is that medicine can sometimes focus too heavily on PSA numbers.
He says, “Treating a PSA is different than treating symptomatic cancer.”
This is one of the more understandable parts of his critique. Many patients do fear becoming trapped in a cycle where lab values begin driving decisions more than how they actually feel.
His concern is overtreatment. He warns that prolonged testosterone suppression can lead to weakness, osteoporosis, depression, loss of sex drive, loss of erections, and loss of muscle mass.
His language is dramatic, but the central concern is clear: some men may feel they are sacrificing too much of what makes life worth living.
Where His View Becomes More Controversial
Dr. Petteruti does not merely question how conventional therapy is used. In parts of the talk, he challenges some widely accepted practices more directly.
He argues against biopsy in strongly absolute terms. He suggests it can “stir things up” and spread disease. That is not the current mainstream medical position. In standard urologic and oncologic practice, biopsy remains a central tool in diagnosis and treatment planning, even though doctors also recognize that every procedure carries some risk.
He is also deeply skeptical of chemotherapy. He says, “Chemotherapy is awful for prostate cancer patients.” He adds, “It does not have, in my view, a role to play in prostate cancer in the approach that I advocate.”
Again, this is not the mainstream position. Chemotherapy is not appropriate for every man with prostate cancer, but in selected advanced cases it has been shown to improve outcomes.
That is why men should be careful not to interpret one physician's critique as settled fact. It is one perspective, not the whole field.
His Alternative: “Bipolar Testosterone Mitigation”
One of the most distinctive sections of the video is where Dr. Petteruti describes the approach he prefers.
He says, “What I like to see happen instead, it is bipolar testosterone mitigation.”
He describes a cycle in which androgen deprivation is used for symptom relief, to reduce pain, improve urine flow, and lower PSA, but not with the goal of crushing testosterone indefinitely.
Then comes the twist. In his words, “After a cycle of androgen deprivation, here's the kicker: you do a cycle of testosterone therapy.”
That idea will sound shocking to many men because for decades testosterone has often been presented as fuel for prostate cancer. Dr. Petteruti directly challenges that older framework. He says the theory that testosterone simply pours “gas on the fire” has been overstated and that newer scrutiny suggests a more complicated reality.
This is where his perspective overlaps, at least partly, with a real area of ongoing research. There has been scientific interest in what is more commonly called bipolar androgen therapy. But it is important to be precise. This remains outside standard care for most men, and long-term outcome data are still limited.
Dr. Petteruti himself acknowledges part of that uncertainty. He says, “It is not proven to make you live longer, but by golly, we're going to aspire to make you live better.”
The Emotional Core of the Video
At heart, this is not just a medical talk. It is a talk about fear, dignity, and the meaning of life under pressure.
Dr. Petteruti says, “Fear drives men to do things they otherwise would never consider.”
That is a powerful point, and one many patients and families will understand immediately. Fear of pain. Fear of decline. Fear of death. Fear of making the wrong choice. Fear can push men toward action before they have fully understood what they are agreeing to.
He repeatedly returns to the idea that some men are more afraid of a long period of weakness, loss of identity, and diminished vitality than they are of death itself.
One of his most memorable lines is this: “Do not let prostate cancer kill you twice, once in the spirit and then again in the body.”
What Makes His Message So Appealing to Some Men
It is not hard to understand why this perspective attracts attention. Many men fear becoming passive patients. Many fear being pushed into treatments that leave them tired, weaker, less sexual, less independent, and emotionally flattened.
Dr. Petteruti speaks directly to that fear. He tells men they still have agency. He tells them they have choices. He tells them that vitality matters.
In one of the strongest lines in the video, he says, “I choose life. I choose vitality.”
For some men, that message will feel deeply liberating.
Why Balance Still Matters
But a balanced article must also say this clearly: a powerful message is not automatically a complete medical roadmap.
Some of Dr. Petteruti's statements reflect opinions that are highly controversial. Some challenge current standards of care directly. Some may appeal emotionally to men who have suffered or who distrust conventional medicine, but that does not make every conclusion medically established.
At the same time, dismissing his message entirely would also miss something important. His emphasis on informed consent, quality of life, and the hidden costs of treatment raises valid questions that many patients should ask.
Men with prostate cancer, especially advanced disease, deserve honest conversations not only about survival curves and scans, but also about fatigue, libido, depression, strength, independence, and whether the burdens of treatment are acceptable to them personally.
What Men Can Take From This, Safely
The safest and most useful takeaway is not that all conventional treatment should be rejected. It is that every man should understand the trade-offs clearly before making life-changing decisions.
Men should ask what the treatment is expected to do. Is it intended to relieve symptoms, slow progression, improve survival, or all three? How likely is each benefit? What are the side effects? How long might they last? What happens if the treatment works for a while and then stops working?
They should also ask what alternatives exist, including less aggressive management, symptom-focused strategies, or second opinions from different specialists.
That is where Dr. Petteruti's talk may have its greatest value. It pushes men to ask harder questions.
The Bottom Line
The dominant message of Dr. Petteruti's video is not simply anti-treatment. It is more personal than that. It is a warning against surrendering the quality of one's life too quickly, too fearfully, or too unquestioningly.
His view is that men should not accept present misery for uncertain future benefit without deep thought.
As he says, “Nobody can guarantee us tomorrow. And I do not want to pay the price of today's misery for some false hope that it'll make me live longer.”
Whether one agrees with all of his medical conclusions or not, that challenge deserves to be heard carefully, examined critically, and weighed against the best available evidence and the values of the individual man sitting in the chair.
Important Disclaimer
This article presents and analyzes views expressed by Dr. Stephen Petteruti in a public video. It is provided for informational and discussion purposes only. It does not endorse every claim made in the video and does not constitute medical advice. Men facing decisions about prostate cancer diagnosis or treatment should consult qualified physicians, review current evidence, and consider obtaining more than one professional opinion before making medical decisions.